3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Infections
3
Recurrence
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Torulopsis
1
Testicular Neoplasms
1
Teratoma, Testicular
1
Teratoma
1
Stem Cell Transplant Complications
1
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Seminoma
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Mycosis Fungoides
1
Mycoses
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukoplakia, Oral
1
Leukemia, Myeloid, Chronic-Phase
1
Interventions
posaconazole
1
liposomal amphotericin B
1
Voriconazole
1
Micafungin
1
Fluconazole
1
Blood Specimen Collection
1
Amphotericin B
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Aspergillosis
×
Fluconazole
×
Clear all
NCT03828773
2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA
Recruiting
410 enrolled